Oluseye O. Bolaji

ORCID: 0000-0002-8295-7150
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS drug development and treatment
  • Pharmacogenetics and Drug Metabolism
  • Malaria Research and Control
  • HIV/AIDS Research and Interventions
  • Drug Transport and Resistance Mechanisms
  • Pharmacological Effects and Toxicity Studies
  • HIV Research and Treatment
  • Pregnancy and Medication Impact
  • Analytical Methods in Pharmaceuticals
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Plant-based Medicinal Research
  • Antibiotics Pharmacokinetics and Efficacy
  • Biosimilars and Bioanalytical Methods
  • Analytical Chemistry and Chromatography
  • Acute Lymphoblastic Leukemia research
  • Computational Drug Discovery Methods
  • Pharmacological Effects of Natural Compounds
  • Monoclonal and Polyclonal Antibodies Research
  • Diet and metabolism studies
  • Mangiferin and Mango Extracts
  • Eicosanoids and Hypertension Pharmacology
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • Cytomegalovirus and herpesvirus research

Obafemi Awolowo University
2016-2025

Adekunle Ajasin University
2024-2025

Ekiti State University
2024-2025

University of Ilorin
2024

Obafemi Awolowo University Teaching Hospitals Complex
2024

Capital University
2024

Global Development Network
2023

Health Net
2023

University of Cape Town
2020

University of Liverpool
2016

Abstract Background Malaria is a major public health issue with substantial risks among vulnerable populations. Currently, the World Health Organization (WHO) recommends SP-IPTp in second and third trimesters. However, efficacy of threatened by emergence sulfadoxine-pyrimethamine resistant malaria parasites due to single nucleotide polymorphisms Plasmodium falciparum dihydrofolate reductase dihydropteroate synthetase genes. This study aimed assess current prevalence Pfdhfr/Pfdhps mutations...

10.1186/s12936-023-04487-5 article EN cc-by Malaria Journal 2023-03-01

Pregnancy‐induced physiological changes alter many drugs' pharmacokinetics. We investigated pregnancy‐induced in efavirenz pharmacokinetics 25 pregnant and 19 different postpartum women stratified from 211 HIV‐positive whom a preliminary pharmacogenetic study had been undertaken. Despite significant CL/F during pregnancy (42.6% increase; P = 0.023), median (range) C min was 1,000 ng/mL (429–5,190) with no change max ( 0.072). However, when for CYP2B6 516G>T (rs3745274) genotype, AUC 0‐24...

10.1002/cpt.43 article EN Clinical Pharmacology & Therapeutics 2015-01-20

<ns4:p>The African Pharmacogenomics Consortium (APC) was formally launched on the 6th September 2018. This white paper outlines its vision, and objectives towards addressing challenges of conducting applying pharmacogenomics in Africa identifies opportunities for advancement individualized drugs use continent. Africa, especially south Sahara, is beset with a huge burden infectious diseases much co-morbidity whose multiplicity intersection are major achieving sustainable development goals...

10.12688/aasopenres.12965.1 preprint EN cc-by AAS Open Research 2019-06-04

ObjectivesThis manuscript describes the development, validation and clinical application of a novel method for quantification antiretroviral drug efavirenz in dried breast milk spots using LC-MS.

10.1093/jac/dku420 article EN Journal of Antimicrobial Chemotherapy 2014-10-17

The antiretroviral drug efavirenz is widely used during breastfeeding. Evaluating its safety requires an understanding of breast milk pharmacokinetics, level breastfed infants' exposure, and potential influence polymorphisms in disposition genes.For this observational study, we investigated plasma pharmacokinetics exposure human immunodeficiency virus positive nursing mothers their infants. We also evaluated variability due to genetic CYP2B6, NR1I3, CYP2A6, ABCB1, ABCB5, ABCG2.CYP2B6 516G>T...

10.1093/cid/civ317 article EN Clinical Infectious Diseases 2015-04-16

Background: All-trans retinoic acid (ATRA) has been shown to have an immunomodulatory activity that could be explored develop adjuvants for vaccination against intestinal or mucosal infections. However, progress limited by the poor chemical stability of ATRA and high concentrations required. This study aimed incorporate high-dose in a previously developed nanoliposome containing Toll-like receptor agonists (TLR) - (GLA) 3M-052, optimising excipient composition physicochemical ATRA. Method:...

10.51412/psnnjp.2025.23 article EN Nigerian Journal of Pharmacy 2025-05-24

ID93 + GLA-LSQ is an adjuvanted recombinant protein vaccine candidate that has demonstrated robust T-cell immunity and reduced bacterial burden in preclinical studies. Here, we explored the strategy of lyophilization by introducing 10% Trehalose as a bulking agent cryoprotectant to develop thermostable single-vial formulation GLA-LSQ. We further examined stability lyophilized formulations stored at 4 37 °C research laboratory field across five study sites. Co-mixed (CoVL) conjugated (ConjVL)...

10.1021/acs.molpharmaceut.5c00150 article EN Molecular Pharmaceutics 2025-03-19

The excretion of chloroquine and the major metabolite, desethylchloroquine, in breast milk was investigated eleven lactating mothers following a single oral dose (600 mg base). average to plasma concentration ratio at 24th hour 6.6 +/‐ 2.4 for 1.5 0.6 desethylchloroquine five volunteers. In other volunteers elimination half‐life 8.8 4.7 days which longer than that saliva (3.9 1.0 days) from same maximum daily drug infant can receive breastfeeding about 0.7% maternal start malaria...

10.1111/j.1365-2125.1987.tb03078.x article EN British Journal of Clinical Pharmacology 1987-04-01

Imatinib mesylate is the first-line drug for treatment of Philadelphia/bcr-abl positive chronic myeloid leukaemia (CML). It known to be metabolized mostly by CYP3A4 and CYP3A5 isoforms while its efflux mediated transporters ABCB1 ABCG2. Genetic polymorphism some these enzymes have been linked with inter-individual variations in pharmacokinetics drug. This study, therefore, investigated influence CYP3A5*3, ABCG2 421C>A 3435 C>T genetic on clinical outcome steady-state trough plasma...

10.1111/jcpt.12424 article EN Journal of Clinical Pharmacy and Therapeutics 2016-07-18

Maternofoetal physiologically-based pharmacokinetic models integrating multi-compartmental maternal and foetal units were developed using Simbiology® to estimate prenatal drug exposure. Processes governing disposition described differential equations with key system drug-specific parameters. Transplacental transfer was modelled as bidirectional passive diffusion benchmarked against those for thalidomide a control. Model-predictions parameters during pregnancy within acceptable ranges...

10.1016/j.ejps.2019.105068 article EN cc-by European Journal of Pharmaceutical Sciences 2019-09-10

ObjectivesThe validation and clinical application of an LC–MS/MS method for the quantification nevirapine in dried blood spots (DBS) breast-milk (DBMS) are presented.

10.1093/jac/dkv174 article EN Journal of Antimicrobial Chemotherapy 2015-06-24

Imatinib, a tyrosine kinase inhibitor, is the drug of choice for treatment chronic myeloid leukemia in Nigeria. Several studies have established interindividual and interpopulation variations imatinib disposition although no pharmacokinetic study been conducted an African population since introduction drug. This explored approach to investigate Nigerians examined involvement some covariates including genetic factors variability with view optimize use this population. A total 250 plasma...

10.1002/jcph.953 article EN The Journal of Clinical Pharmacology 2017-06-15

Moringa oleifera (MO) Lam (Moringaceae) is commonly used as food supplement and medicine in most African countries where malaria also endemic. Therefore, co-administration of MO with antimalarials a possibility. This study investigated the effects leaves powder on pharmacokinetics amodiaquine (AQ) human subjects.Twenty healthy volunteers were recruited for 3-period study. In first period, single dose AQ tablet (10 mg/kg) was administered orally after an overnight fast. After 7-day washout...

10.1111/jcpt.12725 article EN Journal of Clinical Pharmacy and Therapeutics 2018-06-19

The possible occurrence of a kinetic interaction between cyclosporine A and glibenclamide was assessed by reviewing data six posttransplant diabetic patients who received the two drugs concurrently. Coadministration resulted in 57% increase steady-state plasma levels despite normal hepatic renal functions patients. This elevation level is possibly due to an resulting from inhibition CYP3A4-mediated metabolism glibenclamide. observation calls for closer monitoring during concomitant...

10.1097/00007691-199610000-00017 article EN Therapeutic Drug Monitoring 1996-10-01

Context: Co-administration of amodiaquine with MAMA decoction (MD), an herbal antimalarial drug comprising the leaves Mangifera indica L. (Anacardiaceae), Alstonia boonei De Wild (Apocynaceae), Morinda lucida Benth (Rubiaceae) and Azadirachta A. Juss (Meliaceae) was investigated. The practice concurrent administration medicines orthodox drugs is currently on increase globally.Objective: study designed to investigate possible enhancement potency as well herb–drug interaction resulting from...

10.3109/13880209.2016.1155626 article EN Pharmaceutical Biology 2016-04-08

Objectives Previous studies on nevirapine pharmacokinetics during pregnancy reported contradictory findings. Methods The magnitude of pregnancy-induced changes in was investigated a genotype-guided study preceded by pharmacogenetic association six genes involved its disposition. Results CYP2B6 516 G>T and 983 T>C were associated independently with plasma concentrations pregnant (n=110) postpartum (n=122) women used for stratification. NR1I3 540C>T P450 oxidoreductase 1508C>T lower higher...

10.1097/fpc.0000000000000227 article EN Pharmacogenetics and Genomics 2016-05-19

Summary Objective To examine the possibility of a different extent chloroquine (CQ) metabolism in human pregnancy by determining blood level profiles drug and its major metabolite, desethylchloroquine (CQM). Methods Five women early third trimester five non‐pregnant received each single 600 mg oral dose CQ samples were collected at pre‐determined intervals following administration. Plasma concentrations CQM analysed an established HPLC method. Results The C max AUC 0‐‐48 h significantly...

10.1111/j.1365-3156.2004.01227.x article EN Tropical Medicine & International Health 2004-04-29

The Mu ( �) and Theta Θ) classes of glutathione transferase gene, GSTM1 GSTT1 are polymorphic in humans. enzyme deficiencies have been suggested to predispose people lung, bladder colorectal cancer. This study was carried out investigate the distribution Glutathione transferases (GSTs) genotype frequency three major Nigerian ethnic groups with a view understanding implication GST polymorphisms on disease susceptibility. Three hundred unrelated volunteers from Hausa, Ibo Yoruba who consented...

10.5897/jmgg.9000023 article EN Journal of Medical Genetics and Genomics 2011-04-30

Artemether-lumefantrine is often coadministered with efavirenz-based antiretroviral therapy for malaria treatment in HIV-infected women during pregnancy. Previous studies showed changes lumefantrine pharmacokinetics due to interaction efavirenz nonpregnant adults. The influence of pregnancy on this has not been reported. This pharmacokinetic study involved 35 pregnant and 34 HIV-malaria-coinfected receiving was conducted four health facilities Nigeria. Participants received a 3-day standard...

10.1128/aac.01252-18 article EN Antimicrobial Agents and Chemotherapy 2018-08-02
Coming Soon ...